by Christina Arshadi | Sep 20, 2024 | Blog
Immunotherapies were back in the spotlight at the European Society for Medical Oncology’s congress this year, but its limitations are prompting a strategic realignment. Back in style Our analysis of last year’s ESMO congress discovered a notable focus on...
by Commetric | Oct 30, 2023 | Blog
An estimated 33,000 people walked the halls of the European Society for Medical Oncology’s (ESMO) 2023 gathering. The event – which has a reputation for being the most influential oncology congress – is used by many pharma companies as a...
